All Stories

  1. Emerging Nanoformulation-Based Carrier Systems: New Insights into Promising Vaccine Delivery
  2. Gastro-retentive Nanocarriers in Drug Delivery
  3. Reactive oxygen nano-generators for cancer therapy
  4. Emerging ROS-Modulating Technologies for Augmentation of the Wound Healing Process
  5. Current trends in theranostic nanomedicines
  6. Engineering immunity via skin-directed drug delivery devices
  7. Environmental and safety aspects of bionanotechnology
  8. Factors influencing drug toxicity
  9. Food–drug interactions and their implications on oral drug bioavailability
  10. Importance of toxicity testing in drug discovery and research
  11. In silico methods for the prediction of drug toxicity
  12. List of contributors
  13. Methods and models for in vitro toxicity
  14. Principles and concepts in toxicokinetic
  15. Toxicity and toxicokinetic considerations in product development and drug research
  16. Toxicity of pharmaceutical azo dyes
  17. Toxicokinetic and toxicodynamic considerations in drug research
  18. Understanding the concept of signal toxicity and its implications on human health
  19. Recent advancements and future submissions of silica core-shell nanoparticles
  20. Biosimilars accessible in the market for the treatment of cancer
  21. 5-Fluorouracil Loaded Orally Administered WGA-decorated Poly(lacticco- glycolic Acid) Nanoparticles for Treatment of Colorectal Cancer: In Vivo Evaluation
  22. Nanomedicines accessible in the market for clinical interventions
  23. The role of nanoparticles in the treatment of gastric cancer
  24. D-Mannose-Decorated Chitosan Nanoparticles for Enhanced Targeting of 5-Fluorouracil in the Therapy of Colon Cancer
  25. Bioanalytical method development and validation for establishing bioavailability and bioequivalence
  26. Biopharmaceutical considerations in the pediatric and geriatric formulation development
  27. Chronopharmacokinetics
  28. Drug metabolic kinetics
  29. Implications for sex-related issues in clinical pharmacology and biopharmaceutics
  30. Influence of fever on pharmacokinetics of drugs
  31. Kinetics of maternal–fetal drug transfer
  32. List of contributors
  33. List of contributors
  34. Microdialysis: an emerging technique for pharmacokinetic–pharmacodynamic profiling
  35. Molecular mechanisms of circadian rhythm and its influence on the pharmacokinetics of drugs
  36. Overview of biopharmaceutics and pharmacokinetics
  37. Pharmacogenomics and drug metabolism
  38. Pharmacokinetic characterization of drugs and new product development
  39. Pharmacokinetics and biopharmaceutics: “a leader or attendant”
  40. Pharmacokinetics aspects of biotechnological products
  41. Pharmacokinetics aspects of structural modifications in drug design and therapy
  42. Pharmacokinetics modeling in drug delivery
  43. Positron emission tomography as a noninvasive tool in pharmacokinetic studies
  44. Revamping the pharmacokinetics of poorly soluble drugs using different formulations
  45. Software used in ADME computation
  46. “Organ-on-a-chip”-based physiologically relevant pharmacokinetic models
  47. 99mTc-labelled and pH-awakened microbeads entrapping surface-modified lipid nanoparticles for the augmented effect of oxaliplatin in the therapy of colorectal cancer
  48. Development of Metronidazole Loaded Chitosan Nanoparticles Using QbD Approach—A Novel and Potential Antibacterial Formulation
  49. Development and Evaluation of Cholestyramine-Amoxicillin Trihydrate-Loaded Gastro-Retentive Microspheres for Attaining Extended Therapeutic Effect Against H. Pylori Infection
  50. Expedition of Eudragit® Polymers in the Development of Novel Drug Delivery Systems
  51. Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach
  52. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications
  53. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines
  54. Self-microemulsifying drug-delivery system: ongoing challenges and future ahead
  55. Cancer-targeted chemotherapy: Emerging role of the folate anchored dendrimer as drug delivery nanocarrier
  56. 3D printing as an emerging tool in pharmaceutical product development
  57. Dendrimers as novel drug-delivery system and its applications
  58. Hydrotropy, mixed hydrotropy, and mixed solvency as trending concept for solubilization of lipophilic drugs
  59. Resealed erythrocytes (RBCs) and their biomedical application
  60. Gene delivery to tackle diabetic nephropathy
  61. New advances in insulin products
  62. Endosomal escape tendency of drug delivery systems to mediate cytosolic delivery of therapeutics
  63. Gold nanoparticles: An advanced drug delivery and diagnostic tool
  64. Recombinant blood products and therapeutic enzymes: An update
  65. Recent advances in regenerative medicine
  66. Recent advancements in solubilization of hydrophobic drugs
  67. Contributors
  68. List of contributors
  69. Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery
  70. Correction
  71. Irinotecan hydrochloride trihydrate loaded folic acid-tailored solid lipid nanoparticles for targeting colorectal cancer: development, characterization, and in vitro cytotoxicity study using HT-29 cells
  72. Development of a Berberine Loaded Multifunctional Design for the Treatment of Helicobacter pylori Induced Gastric Ulcer
  73. Microemulsion as drug and gene delivery vehicle: an inside story
  74. List of contributors
  75. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation
  76. Recent Advances and Applications of Biosensors in Novel Technology
  77. Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization
  78. A novel sustained release drug–resin complex-based microbeads of ciprofloxacin HCl
  79. Development and in vitro characterization of a multiparticulate delivery system for acyclovir-resinate complex